A lifetime approach to major depressive disorder: The contributions of psychological interventions in preventing relapse and recurrence

Clinical Psychology Review

Volumn 41, Issue , 2015, Pages 16-26

  Bockting, Claudi L ^a,b   Hollon, Steven D ^c   Jarrett, Robin B ^d   Kuyken, Willem ^e   Dobson, Keith ^f  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

Depression; Prevention; Psychological intervention; Recurrence; Relapse

Indexed keywords

COGNITIVE THERAPY; CONCEPTUAL FRAMEWORK; HUMAN; INTERVENTION STUDY; MAJOR DEPRESSION; MINDFULNESS; PREVENTION STUDY; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; RECURRENT DISEASE; RELAPSE; REMISSION; REVIEW; RISK REDUCTION; TREATMENT RESPONSE; DEPRESSIVE DISORDER, MAJOR; OUTCOME ASSESSMENT; PROCEDURES; SECONDARY PREVENTION;

COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); SECONDARY PREVENTION;

EID: 84928709022     PISSN: 02727358     EISSN: 18737811     Source Type: Journal    
DOI: 10.1016/j.cpr.2015.02.003     Document Type: Review

References (110)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, Author, Washington, DC. 4-TR ed.
2. American Psychiatric Association Practice Guideline for the treatment of patients with major depressive disorder 2010, American Psychiatric Association, Arlington, Virginia. 3rd ed.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Publishing, Arlington, VA. 5th ed.
4. Batink T., Peeters F., Geschwind N., van Os J., Wichers M. How does MBCT for depression work? studying cognitive and affective mediation pathways. PLos One 2013, 8(8). (e72778-e72778). 10.1371/journal.pone.0072778.
5. Beck A.T., Rush A.J., Shaw B.F., Emery G. Cognitive therapy of depression 1979, Guilford Press, New York, NY.
6. Beshai S., Dobson K.S., Bockting C.L.H., Quigley L. Relapse and recurrence prevention in depression: Current research and future prospects. Clinical Psychology Review 2011, 31(8):1349-1360. 10.1016/j.cpr.2011.09.003.
7. Bockting C.L.H. Breaking the rhythm of depression: Cognitive behavior therapy and relapse prevention for depression. Psihologijske Teme 2010, 19(2):273-287.
8. Bockting C.L.H., Elgersma H.J., van Rijsbergen G.D., de Jonge P., Ormel J., Buskens E., et al. Disrupting the rhythm of depression: design and protocol of a randomized controlled trial on preventing relapse using brief cognitive therapy with or without antidepressants. BMC Psychiatry 2011, 11:8-8. 10.1186/1471-244X-11-8.
9. Bockting C.L.H., Kok G.D., Smit F., van Valen E., Schoevers R., et al. Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol. BMC Psychiatry 2011, 11:12-12. 10.1186/1471-244X-11-12.
10. Bockting C.L.H., Schene A.H., Spinhoven P., Koeter M.W.J., Wouters L.F., Huyser J., et al. Preventing Relapse/Recurrence in Recurrent Depression With Cognitive Therapy: A Randomized Controlled Trial. Journal of Consulting and Clinical Psychology 2005, 73(4):647-657. 10.1037/0022-006X.73.4.647.
11. Bockting C.L.H., Spinhoven P., Koeter M.W.J., Wouters L.F., Schene A.H. Prediction of Recurrence in Recurrent Depression and the Influence of Consecutive Episodes on Vulnerability for Depression: A 2-Year Prospective Study. Journal of Clinical Psychiatry 2006, 67(5):747-755. 10.4088/JCP.v67n0508.
12. Bockting C.L.H., Spinhoven P., Wouters L.F., Koeter M.W.J., Schene A.H. Long-term effects of preventive cognitive therapy in recurrent depression: A 5.5-year follow-up study. Journal of Clinical Psychiatry 2009, 70(12):1621-1628. 10.4088/JCP.08m04784blu.
13. Bockting C.L.H., ten Doesschate M.C., Spijker J., Spinhoven P., Koeter M.W.J., Schene A.H. Continuation and maintenance use of antidepressants in recurrent depression. Psychotherapy and Psychosomatics 2008, 77(1):17-26. 10.1159/000110056.
14. Burcusa S.L., Iacono W.G. Risk for recurrence in depression. Clinical Psychology Review 2007, 27(8):959-985. 10.1016/j.cpr.2007.02.005.
15. Clark D.M. Implementing NICE guidelines for the psychological treatment of depression and anxiety disorders: The IAPT experience. International Review of Psychiatry 2011, 23(4):318-327. 10.3109/09540261.2011.606803.
16. Clark D.A., Beck A.T., Alford B.A. Scientific foundations of cognitive theory and therapy of depression 1999, John Wiley & Sons Inc., Hoboken, NJ US.
17. Cosci F., Fava G.A. Staging of mental disorders: Systematic review. Psychotherapy and Psychosomatics 2013, 82(1):20-34.
18. Coupland C., Dhiman P., Morriss R., Arthur A., Barton G., Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ[British Medical Journal] 2011, 343(7819):1-15.
19. Cuijpers P., Hollon S.D., van Straten A., Berking M., Bockting C.L.H., Andersson G. Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation medication? A meta-analysis. BMJ Open 2013, 26(3). 10.1136/bmjopen-2012-00254.
20. Dobson K.S., Dozois D.J.A. Risk factors in depression 2008, Elsevier Academic Press, San Diego, CA US. K.S. Dobson, D.J.A. Dozois (Eds.).
21. Dobson K.S., Hollon S.D., Dimidjian S., Schmaling K.B., Kohlenberg R.J., Gallop R.J., et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. Journal of Consulting and Clinical Psychology 2008, 76(3):468-477. 10.1037/0022-006X.76.3.468.
22. Eaton W.W., Shao H., Nestadt G., Lee B.H., Bienvenu O.J., Zandi P. Population-based study of first onset and chronicity in major depressive disorder. Archives of General Psychiatry 2008, 65(5):513-520.
23. Elgersma H.J., Glashouwer K.A., Bockting C.L.H., Penninx B.W.J.H., de Jong P.J. Hidden scars in depression? Implicit and explicit self-associations following recurrent depressive episodes. Journal of Abnormal Psychology 2013, 122(4):951-960. 10.1037/a0034933.
24. Evans M.D., Hollon S.D., DeRubeis R.J., Piasecki J.M. Differential relapse following cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry 1992, 49(10):802-808. 10.1001/archpsyc.1992.01820100046009.
25. Fava G.A. Rational use of antidepressant drugs. Psychotherapy and Psychosomatics 2014, 83(4):197-204. 10.1159/000362803.
26. Fava G.A., Bernardi M., Tomba E., Rafanelli C. Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia. International Journal of Neuropsychopharmacology 2007, 10(6):835-838.
27. Fava G.A., Fabbri S., Sonino N. Residual symptoms in depression: An emerging therapeutic target. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2002, 26(6):1019-1027. 10.1016/S0278-5846(02)00226-9.
28. Fava G.A., Rafanelli C., Grandi S., Canestrari R., Morphy M.A. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. The American Journal of Psychiatry 1998, 155(10):1443-1445.
29. Fava G.A., Rafanelli C., Grandi S., Conti S., Belluardo P. Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Archives of General Psychiatry 1998, 55(9):816-820.
30. Fava G.A., Ruini C., Rafanelli C., Finos L., Conti S., Grandi S. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. The American Journal of Psychiatry 2004, 161(10):1872-1876.
31. Fava G.A., Tomba E., Tossani E. Innovative trends in the design of therapeutic trials in psychopharmacology and psychotherapy. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2013, 40:306-311. 10.1016/j.pnpbp.2012.10.014.
32. Fournier J.C., DeRubeis R.J., Shelton R.C., Hollon S.D., Amsterdam J.D., Gallop R. Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. Journal of Consulting and Clinical Psychology 2009, 77(4):775-787. 10.1037/a0015401.
33. Frank E., Kupfer D.J., Buysse D.J., Swartz H.A., Pilkonis P.A., Houck P.R., et al. Randomized trial of weekly, twice-monthly, and monthly interpersonal psychotherapy as maintenance treatment for women with recurrent depression. The American Journal of Psychiatry 2007, 164(5):761-767. 10.1176/appi.ajp.164.5.761.
34. Frank E., Kupfer D.J., Perel J.M., Cornes C. Three-year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry 1990, 47(12):1093-1099. 10.1001/archpsyc.1990.01810240013002.
35. Frank E., Prien R.F., Jarrett R.B., Keller M.B., Kupfer D.J., Lavori P.W., et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Archives of General Psychiatry 1991, 48(9):851-855.
36. Geddes J.R., Carney S.M., Davies C., Furukawa T.A., Kupfer D.J., Frank E., et al. Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review. The Lancet 2003, 361(9358):653-661.
37. Geschwind N., Peeters F., Huibers M., van Os J., Wichers M. Efficacy of mindfulness-based cognitive therapy in relation to prior history of depression: Randomised controlled trial. The British Journal of Psychiatry 2012, 201(4):320-325. 10.1192/bjp.bp.111.104851.
38. Glue P., Donovan M.R., Kolluri S., Emir B. Meta-analysis of relapse prevention antidepressant trials in depressive disorders. The Australian and New Zealand Journal of Psychiatry 2010, 44(8):697-705. 10.3109/00048671003705441.
39. Gortner E.T., Gollan J.K., Dobson K.S., Jacobson N.S. Cognitive-behavioral treatment for depression: Relapse prevention. Journal of Consulting and Clinical Psychology 1998, 66(2):377-384. 10.1037/0022-006X.66.2.377.
40. Gøtzsche P.C. Why I think antidepressants cause more harm than good. Lancet Psychiatry 2014, 1:104-106. http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(14)70280-9/fulltext.
41. Goyal M., Singh S., Sibinga E.M.S., Gould N.F., Rowland-Seymour A., Sharma R., et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Internal Medicine 2014, 174(3):357-368. 10.1001/jamainternmed.2013.13018.
42. Guidi J., Fava G.A., Fava M., Papakostas G.I. Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: A preliminary meta-analysis. Psychological Medicine 2011, 41(2):321-331.
43. Gyani A., Shafran R., Layard R., Clark D.M. Enhancing recovery rates: Lessons from year one of IAPT. Behaviour Research and Therapy 2013, 51(9):597-606. 10.1016/j.brat.2013.06.004.
44. Hamilton M. A Rating Scale for Depression. Journal of Neurology, Neurosurgery and Psychiatry 1960, 23:56-62.
45. Hansen R., Gaynes B., Thieda P., Gartlehner G., Deveaugh-Geiss A., Krebs E., et al. Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants. Psychiatric Services 2008, 59(10):1121-1130. 10.1176/appi.ps.59.10.1121.
46. Hautzinger M., de Jong-Meyer R., Treiber R., Rudolf G.A. Wirksamkeit Kognitiver Verhaltenstherapie, Pharmakotherapie und deren Kombination bei nicht-endogenen, unipolaren Depressionen. Zeitschrift Für Klinische Psychologie 1996, 25(2):130-145.
47. Holländare F., Anthony S.A., Randestad M., Tillfors M., Carlbring P., Andersson G., et al. Two-year outcome of internet-based relapse prevention for partially remitted depression. Behaviour Research and Therapy 2013, 51(11):719-722.
48. Holländare F., Johnsson S., Randestad M., Tillfors M., Carlbring P., Andersson G., et al. Randomized trial of internet-based relapse prevention for partially remitted depression. Acta Psychiatrica Scandinavica 2011, 124(4):285-294.
49. Hollon S.D., DeRubeis R.J., Shelton R.C., Amsterdam J.D., Salomon R.M., O'Reardon J.P., et al. Prevention of Relapse Following Cognitive Therapy vs Medications in Moderate to Severe Depression. Archives of General Psychiatry 2005, 62(4):417-422. 10.1001/archpsyc.62.4.417.
50. Hollon S.D., Stewart M.O., Strunk D. Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety 2006, 285-315. Annual Reviews, Palo Alto, CA US. S.T. Fiske, A.E. Kazdin, D.L. Schacter (Eds.).
51. Huijbers M.J., Spijker J., Donders A.R., van Schaik D.J.F., van Oppen P., Ruhé H.G., et al. Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: Trial design and protocol of the MOMENT study. BMC Psychiatry 2012, 12. 10.1186/1471-244X-12-125.
52. Imel Z.E., Malterer M.B., McKay K.M., Wampold B.E. A meta-analysis of psychotherapy and medication in unipolar depression and dysthymia. Journal of Affective Disorders 2008, 110(3):197-206. 10.1016/j.jad.2008.03.018.
53. Jacobson N.S., Fruzzetti A.E., Dobson K., Whisman M., Hops H. Couple therapy as a treatment for depression: II. The effects of relationship quality and therapy on depressive relapse. Journal of Consulting and Clinical Psychology 1993, 61(3):516-519. 10.1037/0022-006X.61.3.516.
54. Jarrett R.B., Basco M.R., Risser R., Ramanan J., Marwill M., Kraft D., et al. Is there a role for continuation phase cognitive therapy for depressed outpatients?. Journal of Consulting and Clinical Psychology 1998, 66(6):1036-1040.
55. Jarrett R.B., Kraft D., Doyle J., Foster B.M., Eaves G.G., Silver P.C. Preventing recurrent depression using cognitive therapy with and without a continuation phase. Archives of General Psychiatry 2001, 58(4):381-388. 10.1001/archpsyc.58.4.381.
56. Jarrett R.B., Minhajuddin A., Borman P.D., Dunlap L., Segal Z.V., Kidner C.L., et al. Cognitive reactivity, dysfunctional attitudes, and depressive relapse and recurrence in cognitive therapy responders. Behaviour Research and Therapy 2012, 50(5):280-286. 10.1016/j.brat.2012.01.008.
57. Jarrett R.B., Minhajuddin A., Gershenfeld H., Friedman E.S., Thase M.E. Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: A randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo. JAMA Psychiatry 2013, 70(11):1152-1160. 10.1001/jamapsychiatry.2013.1969.
58. Jarrett R.B., Thase M.E. Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up. Contemporary Clinical Trials 2010, 31(4):355-377. 10.1016/j.cct.2010.04.004.
59. Jarrett R.B., Vittengl J.R., Clark L.A. How much cognitive therapy, for which patients, will prevent depressive relapse?. Journal of Affective Disorders 2008, 111(2-3):185-192. 10.1016/j.jad.2008.02.011.
60. Jarrett R.B., Vittengl J.R., Doyle K., Clark L.A. Changes in cognitive content during and following cognitive therapy for recurrent depression: substantial and enduring, but not predictive of change in depressive symptoms. Journal of Consulting and Clinical Psychology 2007, 75(3):432-446.
61. Kaymaz N., van Os J., Loonen A.J.M., Nolen W.A. Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. The Journal of Clinical Psychiatry 2008, 69(9):1423-1436.
62. Kessing L.V., Hansen M.G., Andersen P.K., Angst J. The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders - a life-long perspective. Acta Psychiatrica Scandinavica 2004, 109(5):339-344.
63. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005, 62(6):593-602. 10.1001/archpsyc.62.6.593.
64. Kok G.D., Bockting C.L.H., Burger H., Hannig W., Pijnenborg G.H.M., Cuijpers P., et al. Double trouble: Does co-morbid chronic somatic illness increase risk for recurrence in depression? A systematic review. PLoS ONE 2013, 8(3). 10.1371/journal.pone.0057510.
65. Kok G.D., Burger H., Riper H., Cuijpers P., Dekker J., van Marwijk H.W.J., et al. The short term effect of Mobile Internet-based Cognitive Therapy on the course of depressive symptoms in remitted recurrently depressed patients: results of a randomized controlled trial. Psychotherapy and Psychosomatics 2015, 84(2):90-99.
66. Kordy H., Backenstrass M., Hüsing J., Wolf M., Aulich K., Bürgy M., et al. Supportive monitoring and disease management through the internet: an internet-delivered intervention strategy for recurrent depression. Contemporary Clinical Trials 2013, 36(2):327-337. 10.1016/j.cct.2013.08.005.
67. Kupfer D.J. Long-term treatment of depression. The Journal of Clinical Psychiatry 1991, 52:28-34. (Suppl.).
68. Kupfer D.J., Frank E., Phillips M.L. Major depressive disorder: New clinical, neurobiological, and treatment perspectives. The Lancet 2012, 379(9820):1045-1055. 10.1016/S0140-6736(11)60602-8.
69. Kuyken W., Byford S., Byng R., Dalgleish T., Lewis G., Taylor R., et al. Study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment in the prevention of depressive relapse/recurrence: the PREVENT trial. Trials 2010, 11:99. 10.1186/1745-6215-11-99.
70. Kuyken W., Byford S., Taylor R.S., Watkins E., Holden E., White K., et al. Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. Journal of Consulting and Clinical Psychology 2008, 76(6):966-978. 10.1037/a0013786.
71. Kuyken W., Dalgleish T., Holden E.R. Advances in cognitive-behavioural therapy for unipolar depression. The Canadian Journal of Psychiatry/La Revue Canadienne De Psychiatrie 2007, 52(1):5-13.
72. Lewinsohn P.M., Rohde P., Seeley J.R. Adolescent psychopathology: III. The clinical consequences of comorbidity. Journal of the American Academy of Child & Adolescent Psychiatry 1995, 34(4):510-519. 10.1097/00004583-199504000-00018.
73. Lok A., Bockting C.L.H., Koeter M.W.J., Snieder H., Assies J., Mocking R.J.T., et al. Interaction between the MTHFR C677T polymorphism and traumatic childhood events predicts depression. Translational Psychiatry 2013, 3:e288. 10.1038/tp.2013.60.
74. Lok A., Mocking R.J.T., Ruhé H.G., Visser I., Koeter M.W.J., Assies J., et al. Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression. Psychoneuroendocrinology 2012, 37(7):892-902. 10.1016/j.psyneuen.2011.10.005.
75. Ma S.H., Teasdale J.D. Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Journal of Consulting and Clinical Psychology 2004, 72(1):31-40. 10.1037/0022-006X.72.1.31.
76. Marcus S.C., Olfson M. National trends in the treatment for depression from 1998 to 2007. Archives of General Psychiatry 2010, 67(12):1265-1273. 10.1001/archgenpsychiatry.2010.151.
77. Miranda J., Persons J.B. Dysfunctional attitudes are mood-state dependent. Journal of Abnormal Psychology 1988, 97(1):76-79. 10.1037/0021-843X.97.1.76.
78. Moffitt T.E., Caspi A., Taylor A., Kokaua J., Milne B.J., Polanczyk G., et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychological Medicine: A Journal of Research in Psychiatry and the Allied Sciences 2010, 40(6):899-909. 10.1017/S0033291709991036.
79. Mueller T.I., Leon A.C., Keller M.B., Solomon D.A., Endicott J., Coryell W., et al. Recurrence after recovery from major depressive disorder during 15years of observational follow-up. The American Journal of Psychiatry 1999, 156(7):1000-1006.
80. National Institute for Health and Clinical Excellence Depression: management of depression in adults. Clinical Practice Guideline 2010, National Institute for Health and Clinical Excellence, Londen, UK. Updated ed.
81. Oestergaard S., Møldrup C. Optimal duration of combined psychotherapy and pharmacotherapy for patients with moderate and severe depression: a meta-analysis. Journal of Affective Disorders 2011, 131(1-3):24-36. 10.1016/j.jad.2010.08.014.
82. Olfson M., Marcus S.C. National patterns in antidepressant medication treatment. Archives of General Psychiatry 2009, 66(8):848-856. 10.1001/archgenpsychiatry.2009.81.
83. Olfson M., Marcus S.C., Druss B., Elinson L., Tanielian T., Pincus H.A. National trends in the outpatient treatment of depression. JAMA: Journal of the American Medical Association 2002, 287(2):203-209.
84. Ormel J., Oldehinkel A.J., Sijtsema J., van Oort F., Raven D., Veenstra R., et al. The TRacking Adolescents' Individual Lives Survey (TRAILS): Design, current status, and selected findings. Journal of the American Academy of Child & Adolescent Psychiatry 2012, 51(10):1020-1036. 10.1016/j.jaac.2012.08.004.
85. Paykel E.S., Scott J., Cornwall P.L., Abbott R., Crane C., Pope M., et al. Duration of relapse prevention after cognitive therapy in residual depression: Follow-up of controlled trial. Psychological Medicine 2005, 35(1):59-68. 10.1017/S003329170400282X.
86. Paykel E.S., Scott J., Teasdale J.D., Johnson A.L., Garland A., Moore R., et al. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Archives of General Psychiatry 1999, 56(9):829-835.
87. Penninx B.W.J.H., Beekman A.T.F., Johannes H.S., Zitman F.G., Nolen W.A., Spinhoven P., et al. The Netherlands Study of Depression and Anxiety (NESDA): Rationale, objectives and methods. International Journal of Methods in Psychiatric Research 2008, 17(3):121-140. 10.1002/mpr.256.
88. Perlis R.H., Nierenberg A.A., Alpert J.E., Pava J., Matthews J.D., Buchin J., et al. The effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder. Journal of Clinical Psychopharmacology 2002, 22(5):474-480. 10.1097/00004714-200210000-00006.
89. Piet J., Hougaard E. The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: A systematic review and meta-analysis. Clinical Psychology Review 2011, 31(6):1032-1040. 10.1016/j.cpr.2011.05.002.
90. Pigott H.E., Leventhal A.M., Alter G.S., Boren J.J. Efficacy and effectiveness of antidepressants: Current status of research. Psychotherapy and Psychosomatics 2010, 79(5):267-279. 10.1159/000318293.
91. Reynolds C.F.I., Dew M.A., Pollock B.G., Mulsant B.H., Frank E., Miller M.D., et al. Maintenance Treatment of Major Depression in Old Age. The New England Journal of Medicine 2006, 354(11):1130-1138. 10.1056/NEJMoa052619.
92. Reynolds C.F.I., Frank E., Perel J.M., Imber S.D., Cornes C., Miller M.D., et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59years. JAMA: Journal of the American Medical Association 1999, 281(1):39-45. 10.1001/jama.281.1.39.
93. Saxena S., Thornicroft G., Knapp M., Whiteford H. Resources for mental health: scarcity, inequity, and inefficiency. Lancet 2007, 370(9590):878-889.
94. Segal Z.V., Bieling P., Young T., MacQueen G., Cooke R., Martin L., et al. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Archives of General Psychiatry 2010, 67(12):1256-1264. 10.1001/archgenpsychiatry.2010.168.
95. Segal Z.V., Gemar M., Williams S. Differential cognitive response to a mood challenge following successful cognitive therapy or pharmacotherapy for unipolar depression. Journal of Abnormal Psychology 1999, 108(1):3-10.
96. Segal Z.V., Kennedy S., Gemar M., Hood K., Pedersen R., Buis T. Cognitive reactivity to sad mood provocation and the prediction of depressive relapse. Archives of General Psychiatry 2006, 63(7):749-755.
97. Segal Z.V., Williams J.M., Teasdale J.D. Mindfulness-based cognitive therapy for depression 2013, Guilford Press, New York, NY US. 2nd ed.
98. Shapiro D.A., Rees A., Barkham M., Hardy G. Effects of treatment duration and severity of depression on the maintenance of gains after cognitive-behavioral and psychodynamic-interpersonal psychotherapy. Journal of Consulting and Clinical Psychology 1995, 63(3):378-387. 10.1037/0022-006X.63.3.378.
99. Shea M.T., Elkin I., Imber S.D., Sotsky S.M., Watkins J.T., Collins J.F., et al. Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Archives of General Psychiatry 1992, 49(10):782-787.
100. Simons A.D., Murphy G.E., Levine J.L., Wetzel R.D. Cognitive therapy and pharmacotherapy for depression: Sustained improvement over one year. Archives of General Psychiatry 1986, 43(1):43-48. 10.1001/archpsyc.1986.01800010045006.
101. Solomon D.A., Keller M.B., Leon A.C., Mueller T.I., Lavori P.W., Shea M.T., et al. Multiple recurrences of major depressive disorder. The American Journal of Psychiatry 2000, 157(2):229-233. 10.1176/appi.ajp.157.2.229.
102. Spijker J., Bockting C.L.H., Meeuwissen J.A.C., van Vliet I.M., Emmelkamp P.M.G., Hermens M.L.M., et al. Multidisciplinaire richtlijn Depressie. Richtlijn voor de diagnostiek, behandeling en begeleiding van volwassen patiënten met een depressieve stoornis 2013, Trimbos Instituut, Utrecht, The Netherlands. 3rd ed.
103. Stangier U., Hilling C., Heidenreich T., Risch A.K., Barocka A., Schlösser R., et al. Maintenance cognitive-behavioral therapy and manualized psychoeducation in the treatment of recurrent depression: a multicenter prospective randomized controlled trial. The American Journal of Psychiatry 2013, 170(6):624-632. 10.1176/appi.ajp.2013.12060734.
104. Teasdale J.D. Cognitive vulnerability to persistent depression. Cognition and Emotion 1988, 2(3):247-274. 10.1080/02699938808410927.
105. Teasdale J.D., Scott J., Moore R.G., Hayhurst H., Pope M., Paykel E.S. How does cognitive therapy prevent relapse in residual depression? Evidence from a controlled trial. Journal of Consulting and Clinical Psychology 2001, 69(3):347-357.
106. Teasdale J.D., Segal Z.V., Williams J.M., Ridgeway V.A., Soulsby J.M., Lau M.A. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology 2000, 68(4):615-623.
107. Thase M.E., Simons A.D., McGeary J., Cahalane J.F. Relapse after cognitive behavior therapy of depression: Potential implications for longer courses of treatment. The American Journal of Psychiatry 1992, 149(8):1046-1052.
108. van Rijsbergen G.D., Bockting C.L.H., Burger H., Spinhoven P., Koeter M.W.J., Ruhé H.G., et al. Mood reactivity rather than cognitive reactivity is predictive of depressive relapse: A randomized study with 5.5-year follow-up. Journal of Consulting and Clinical Psychology 2013, 81(3):508-517. (Supplemental). 10.1037/a0032223.
109. Vittengl J.R., Clark L.A., Dunn T.W., Jarrett R.B. Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects. Journal of Consulting and Clinical Psychology 2007, 75(3):475-488.
110. Williams J.M., Crane C., Barnhofer T., Brennan K., Duggan D.S., Fennell M.J.V., et al. Mindfulness-based cognitive therapy for preventing relapse in recurrent depression: A randomized dismantling trial. Journal of Consulting and Clinical Psychology 2014, 82(2):275-286. 10.1037/a0035036.